The PE Ratio as of November 2024 (TTM) for Genenta Science S.p.A. (GNTA) is -9.03

According to Genenta Science S.p.A.’s latest financial reports and current stock price. The company's current PE Ratio is -9.03. This represents a change of 27.91% compared to the average of -7.06 of the last 4 quarters.

Genenta Science S.p.A. (GNTA) Historical PE Ratio (quarterly & annually)

How has GNTA PE Ratio performed in the past?

The mean historical PE Ratio of Genenta Science S.p.A. over the last ten years is -26.41. The current -9.03 PE Ratio has changed 3.32% with respect to the historical average. Over the past ten years (40 quarters), GNTA's PE Ratio was at its highest in in the June 2023 quarter at -3.67. The PE Ratio was at its lowest in in the December 2021 quarter at -50.08.

Genenta Science S.p.A. (GNTA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Genenta Science S.p.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genenta Science S.p.A. (GNTA) Average PE Ratio

How has GNTA PE Ratio performed in the past?

The current PE Ratio of Genenta Science S.p.A. (GNTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Genenta Science S.p.A. (GNTA) PE Ratio vs. Peers

How is GNTA’s PE Ratio compared to its peers?

Genenta Science S.p.A.’s PE Ratio is less than Molecular Partners AG (-2.50), less than MediciNova, Inc. (-0.04), less than Anebulo Pharmaceuticals, Inc. (-4.78), greater than Champions Oncology, Inc. (-18.21), greater than Cyteir Therapeutics, Inc. (-9.12), less than PMV Pharmaceuticals, Inc. (-1.61), less than Eliem Therapeutics, Inc. (-2.42), less than Pharvaris N.V. (-8.69), less than PepGen Inc. (-1.65), less than Mineralys Therapeutics, Inc. (-4.06), greater than Janux Therapeutics, Inc. (-45.40), less than Rezolute, Inc. (-4.94), less than Opthea Limited (0), less than Pardes Biosciences, Inc. (-1.15), less than AN2 Therapeutics, Inc. (-1.36), less than Aerovate Therapeutics, Inc. (-0.66), less than Adagene Inc. (-0.91), less than null (-3.02),

Build a custom stock screener for Genenta Science S.p.A. (GNTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genenta Science S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genenta Science S.p.A. (GNTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genenta Science S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.